What is the market cap of Bluemtec?

The market capitalisation of Bluemtec was ₩65B at the close on Oct 30, 2026.

Who are the largest shareholders of Bluemtec?

According to the latest official filings, the largest reported holders are Yeon Je-ryang (22.71%, as of Oct 14, 2026); KDB Investment (21.07%, as of Oct 14, 2026); Orion Asset Management (7.99%, as of Jul 7, 2026).

When is the next earnings report from Bluemtec?

Korean companies rarely announce results dates in advance. Based on when Bluemtec filed the same report in past years, its next 3q results is expected between Nov 3, 2026 and Nov 14, 2026.

KOSDAQ · 439580 · Retail & Trade · ₩439580

Bluemtec블루엠텍

439580 · KOSDAQ · ₩439580 · 블루엠텍

₩1,928▲ ₩18 (0.94%)End-of-day · Oct 30, 2026 · End-of-day prices.

Trade

Price · 1Y −61.52%

Market cap: ₩65B
Enterprise value: ₩87B
P/E: 15.5×
P/B: 1.3×
Dividend yield: 0.0%
ROE: 8.6%
Net margin: 2.1%

Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.

52-week range−64.8% from the high

₩1,341Today: ₩1,900 – ₩2,070₩5,480

Returns

1W−9.5%
1M−35.7%
3M+20.5%
6M−41.9%
YTD−56.4%
1Y−61.5%

Volume today: 421,876; 0.4× the 20-day average
Traded today: ₩841M
Listed shares: 33,846,547
EPS (12 months): ₩124; Earnings yield 6.5%

Sell Buy

AI researchResearch being writtenOur AI is writing a report on this company from filed data, prices and news. Check back soon.

Upcoming dates

Full calendar →

🎁 Gift this stock

Send a friend ₩100,000 of paper money in this stock. They get it when they join.

X f WA TG r/in @

Signals

Quiet

BuzzQuietBuzz 29 of 100 (50 is a normal day for this stock).
SentimentMixedNews: The two amended filings are neutral in tone and give no details. Community: 0 bullish, 0 bearish posts this week.
MomentumWeak-27.8% over the last month; the price is below its 20-day average.
News impactLow2 news items and filings in two weeks; 0 rated high impact, 0 medium.

Signals describe activity, not recommendations. Not financial advice.

Bluemtec stock overview

Bluemtec (블루엠텍, KRX: 439580) is listed on KOSDAQ, in the Retail & Trade sector. Bluem Tech's subsidiary-style business centers on a Korean e-commerce pharmaceutical distribution model: the company is a licensed prescription drug seller that sells mainly prescription drugs through e-commerce platforms. Its shares closed at ₩1,928 on Oct 30, 2026, up 0.94% on the day, giving it a market value of ₩65B.

Market cap: ₩65B
Sector: Retail & Trade
Latest price change: +0.94%
As of: Oct 30, 2026
Main business: Bluem Tech's subsidiary-style business centers on a Korean e-commerce pharmaceutical distribution model: the company is a licensed prescription drug seller that sells mainly prescription drugs through e-commerce platforms.

Quick answers about Bluemtec

What does Bluemtec do?: Bluem Tech's subsidiary-style business centers on a Korean e-commerce pharmaceutical distribution model: the company is a licensed prescription drug seller that sells mainly prescription drugs through e-commerce platforms. Its platforms include BluePharmKorea for hospitals and clinics, KoolPharm for pharmacies, and BlueDoc, a recruitment platform for medical staff. Its main products are non-reimbursed prescription drugs and vaccines, with other products including quasi-drugs, consumables, and reimbursed drugs, and it also offers advertising, IT, and logistics services to clinics and pharmaceutical companies.
What is the market cap of Bluemtec?: The market capitalisation of Bluemtec was ₩65B at the close on Oct 30, 2026.
Who are the largest shareholders of Bluemtec?: According to the latest official filings, the largest reported holders are Yeon Je-ryang (22.71%, as of Oct 14, 2026); KDB Investment (21.07%, as of Oct 14, 2026); Orion Asset Management (7.99%, as of Jul 7, 2026).
When is the next earnings report from Bluemtec?: Korean companies rarely announce results dates in advance. Based on when Bluemtec filed the same report in past years, its next 3q results is expected between Nov 3, 2026 and Nov 14, 2026.

Company profile

Bluem Tech's subsidiary-style business centers on a Korean e-commerce pharmaceutical distribution model: the company is a licensed prescription drug seller that sells mainly prescription drugs through e-commerce platforms. Its platforms include BluePharmKorea for hospitals and clinics, KoolPharm for pharmacies, and BlueDoc, a recruitment platform for medical staff. Its main products are non-reimbursed prescription drugs and vaccines, with other products including quasi-drugs, consumables, and reimbursed drugs, and it also offers advertising, IT, and logistics services to clinics and pharmaceutical companies.

Written by AI from the company's latest annual report.

Korean name: 블루엠텍
Sector: Retail & Trade
Themes: —
CEO: 김준석
Founded: Mar 2015
Listed: Dec 2023
Listed shares: 33,846,547
Fiscal year ends: Month 12
Website: www.bluemtec.com

Similar companies

Samsung C&T028260 · ₩51T₩312,000−3.55%
POSCO International047050 · ₩8.6T₩48,650−1.22%
ISC095340 · ₩3.3T₩155,800−6.26%
Youngone111770 · ₩3.1T₩69,100+0.88%
Dong SUH Companies026960 · ₩2.8T₩28,450+2.34%
SK Gas018670 · ₩2.4T₩256,000+1.39%
Lotte Shopping023530 · ₩2.3T₩81,900−0.49%
Shinsegae004170 · ₩2.3T₩245,000−1.21%

Recent filings

See all

Amended: Change of largest shareholderOct 30, 2026
Amended: Convertible bond issue decisionOct 30, 2026
Acquisition of Bonds Before Maturity After Issuance of Bonds with Warrants (Including Overseas Bonds with Warrants) (3rd Series)Oct 15, 2026
5%+ holding reportOct 14, 2026
5%+ holding reportOct 14, 2026

Titles in Korean until English translations are added.

Key numbers

Volume: 421,876
Traded value: ₩841M
Day range: ₩1,900 – ₩2,070
Revenue (TTM): ₩205B
Operating margin: −0.3%
Net margin: 2.1%
ROE: 8.6%
Revenue growth (last year): +39.5%
Liabilities to equity: 131%
Foreign ownership: 2.66%
Short balance: 0.47%

Trailing 12 months from filed financial statements, as of H1 2026.

Who owns Bluemtec?

See all

Yeon Je-ryang연제량Executive director · 사실상지배주주5% reportInsider report22.71%7.7M sharesas of Oct 14, 2026
KDB Investment산은인베스트먼트5% report21.07%7.1M sharesas of Oct 14, 2026
Orion Asset Management오라이언자산운용5% report7.99%2.9M sharesas of Jul 7, 2026
Kim Hyun-soo김현수CEOInsider report7.34%2.5M sharesas of May 15, 2025
A-One Asset Management에이원자산운용5% report6.21%2.2M sharesas of Jul 13, 2026
GV A Asset Management지브이에이자산운용5% report3.89%1.4M sharesas of Aug 5, 2026

From official filings only: 5% reports and executives' and major shareholders' reports (Korea), and US funds' Form N-PORT and US managers' Form 13F (ADRs) reports. Each holder shows its latest report and the date it was as of; the same holder in two reports is shown once.

Institutions holding 5% or more

All institutions →

Only holdings of 5% or more are disclosed. We add up every reported trade (shares × the price in the filing, or that day's close when the filing gives none) to estimate an average cost, then value the stake at the latest close. Shares held before the first reported trade count at that day's close. It is an estimate, not the institution's real return.

Also known as: Bluemtec / 블루엠텍 / 439580 / KRX:439580

Source: KRX statistical information